Literature DB >> 10466735

Positive and negative symptoms and regional cerebral perfusion in antipsychotic-naive schizophrenic patients: a high-resolution SPECT study.

S K Min1, S K An, D I Jon, J D Lee.   

Abstract

In 17 antipsychotic-naive schizophrenic patients, the scores of positive and negative symptoms of schizophrenia were correlated with relative regional cerebral perfusion measured by 99m-Tc-ECD (ethyl cysteinate dimer) single photon emission computed tomography (SPECT). Scans were performed in subjects at rest. The negative symptom dimension was significantly correlated with a decreased level of perfusion in the left thalamic region. Other non-significant trends were also observed; the positive symptom dimension was related to decreased perfusion in the left temporal region and to increased perfusion in the right frontal region, while the negative symptom dimension was related to increased perfusion in the left frontal region. These findings suggest that the positive and negative symptoms of schizophrenia are related to dysfunctions in different regions of the brain and different lateralized patterns of dysfunction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10466735     DOI: 10.1016/s0925-4927(99)00014-1

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  9 in total

1.  Resting quantitative cerebral blood flow in schizophrenia measured by pulsed arterial spin labeling perfusion MRI.

Authors:  Amy Pinkham; James Loughead; Kosha Ruparel; Wen-Chau Wu; Eve Overton; Raquel Gur; Ruben Gur
Journal:  Psychiatry Res       Date:  2011-08-09       Impact factor: 3.222

Review 2.  Neurobiological background of negative symptoms.

Authors:  Silvana Galderisi; Eleonora Merlotti; Armida Mucci
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-03-24       Impact factor: 5.270

3.  Delusions in individuals with schizophrenia: factor structure, clinical correlates, and putative neurobiology.

Authors:  David Kimhy; Ray Goetz; Scott Yale; Cheryl Corcoran; Dolores Malaspina
Journal:  Psychopathology       Date:  2005-11-01       Impact factor: 1.944

Review 4.  60 Years of Achievements by KSNM in Neuroimaging Research.

Authors:  Jae Seung Kim; Hye Joo Son; Minyoung Oh; Dong Yun Lee; Hae Won Kim; Jungsu Oh
Journal:  Nucl Med Mol Imaging       Date:  2022-01-15

Review 5.  Thalamic nuclear abnormalities as a contributory factor in sudden cardiac deaths among patients with schizophrenia.

Authors:  Fulvio A Scorza; Andrea Schmitt; Roberta M Cysneiros; Ricardo M Arida; Esper A Cavalheiro; Wagner F Gattaz
Journal:  Clinics (Sao Paulo)       Date:  2010-05       Impact factor: 2.365

6.  Study of childhood onset schizophrenia (COS) using SPECT and neuropsychological assessment.

Authors:  Savita Malhotra; Nitin Gupta; Anish Bhattacharya; Mehak Kapoor
Journal:  Indian J Psychiatry       Date:  2006-10       Impact factor: 1.759

7.  Deletion of the STOP gene, a microtubule stabilizing factor, leads only to discrete cerebral metabolic changes in mice.

Authors:  Ryosuke Hanaya; Estelle Koning; Arielle Ferrandon; Annie Schweitzer; Annie Andrieux; Astrid Nehlig
Journal:  J Neurosci Res       Date:  2008-03       Impact factor: 4.164

8.  Abnormal hippocampal-thalamic white matter tract development and positive symptom course in individuals at ultra-high risk for psychosis.

Authors:  Jessica A Bernard; Joseph M Orr; Vijay A Mittal
Journal:  NPJ Schizophr       Date:  2015

Review 9.  Magnetic resonance imaging in studying schizophrenia, negative symptoms, and the glutamate system.

Authors:  Oliver Gruber; Antonella Chadha Santuccione; Helmut Aach
Journal:  Front Psychiatry       Date:  2014-04-03       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.